Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | GPX4 | P36969 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5523913 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL396919 | 0.98 | ALDH1A1 (0.43) | ALDH1A1TP53NPC1GPX4RAB9A | |
| Ammonia Solution, Strong SCHEMBL28248232 | 0.97 | ALDH1A1 (0.42) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL30848466 | 0.97 | ALDH1A1 (0.42) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL29808662 | 0.97 | ALDH1A1 (0.42) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL27960646 | 0.95 | CYP1A2 (0.42) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL9487613 | 0.94 | CYP1A2 (0.43) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL9360416 | 0.93 | CYP1A2 (0.49) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL1592182 | 0.92 | CYP1A2 (0.50) | ALDH1A1TP53NPC1GPX4RAB9A | |
| SCHEMBL29540381 | 0.90 | CYP1A2 (0.49) | ALDH1A1TP53NPC1GPX4RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170010290-A1 | METHODS OF DETERMINING A HIGH DENSITY LIPOPROTEIN PHOSPHOLIPID LEVEL IN A SAMPLE | MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS ADMINISTRATIVE AGENT | 2017-01-12 | — | — | US | claimed |
| US-9828624-B2 | Driving patient compliance with therapy | BOSTON HEART DIAGNOSTICS CORPORATION (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170010290-A1 | METHODS OF DETERMINING A HIGH DENSITY LIPOPROTEIN PHOSPHOLIPID LEVEL IN A SAMPLE | MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS ADMINISTRATIVE AGENT | 2017-01-12 | — | — | US | disclosed |
| EP-3025157-A2 | DRIVING PATIENT COMPLIANCE WITH THERAPY | Boston Heart Diagnostics Corporation (US) | 2016-06-01 | — | — | EP | disclosed |
| EP-2900832-A1 | METHODS FOR DETERMINING WHETHER A PATIENT SHOULD BE ADMINISTERED A DRUG THAT INHIBITS CHOLESTEROL ABSORPTION | Boston Heart Diagnostics Corporation (US) | 2015-08-05 | — | — | EP | disclosed |
| WO-2015013515-A2 | DRIVING PATIENT COMPLIANCE WITH THERAPY | BOSTON HEART DIAGNOSTICS CORPORATION (US) | 2015-01-29 | — | — | WO | disclosed |
| US-20150031058-A1 | Driving Patient Compliance with Therapy | BOSTON HEART DIAGNOSTICS CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
| US-20140088073-A1 | METHODS FOR DETERMINING WHETHER A PATIENT SHOULD BE ADMINISTERED A DRUG THAT INHIBITS CHOLESTEROL ABSORPTION | BOSTON HEART DIAGNOSTICS CORPORATION (US) | 2014-03-27 | — | — | US | disclosed |
| US-6448029-B1 | USING NUCLEOTIDE DIPHOSPHATE OR TRIPHOSPHATE | KYOWA MEDEX CO., LTD. (JP) | 2002-09-10 | — | — | US | disclosed |
| US-20020031794-A1 | Method and reagent for quantitative determination of 1,5- anhydroglucitol | TAZOE SAKAE (JP) | 2002-03-14 | — | — | US | disclosed |
| US-6309852-B1 | CONTACTING THE SAMPLE WITH AN ENZYME SUCH AS NUCLEOSIDE DIPHOSPHATE, TRIPHOSPHATE AND NUCLEOSIDE DEPENDENT ENZYMES SYSTEM WHICH CONVERTS GLUCOSE INTO FRUCTOSE 1,6-DIPHOSPHATE AND 1,5-ANHYDROGLUCITOL (1,5-AG)TO 1,5-AG-6-PHOSPHATE | KYOWA MEDEX CO., LTD. (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-1008657-A2 | Method and reagent for quantitative determination of 1,5-anhydroglucitol | KYOWA MEDEX CO., LTD. (JP) | 2000-06-14 | — | — | EP | disclosed |